Assesses continuous manufacturing (CM) in pharma green transition, comparing efficiency gains with traditional production amid tech/regulatory barriers and ESG impacts.
Active pharmaceutical ingredients (APIs) are the active ingredients used in pharmaceutical manufacturing and are formulated with excipients to create the finished drug form.
This analysis reveals a paradox: 85% of APIs for U.S. branded drugs are imported (43% from Europe). Proposed tariffs threaten global supply chains, forcing pharmaceutical companies to restructure sourcing strategies.
Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.
AdvertisingEmail to: Julia.zhang@imsinoexpo.com
Media CooperationEmail to: Jennifer.Yang@imsinoexpo.com
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!